Newsfile Corp
29 Sept 2026, 18:45 UTC · 1h ago
Verdict
Headline takes no side. We score BBNX −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Beta Bionics, Inc. (BBNX) regarding stock purchased between July 30, 2025, and February 24, 2026.
Newpress release dated September 29, 2026
More negative than 76% of claims this week
The FDA issued a warning letter on February 24, 2026, detailing violations and the company's failure to report serious patient incidents.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 68% of claims this week
Beta Bionics experienced a 37% one-day stock price decline on January 8, 2026, following a miss on new iLet patient starts.
Priced inoccurred on January 8, 2026
More negative than 62% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
Facing a class action lawsuit following FDA warning letters and allegations of life-threatening device malfunctions.
More negative than 72% of ticker scores this week
Mentioned in the context of an approaching lead plaintiff deadline for a legal action.
More negative than 72% of ticker scores this week
Mentioned in the context of an approaching securities class action deadline.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−5.1%
Price agrees with the score
$19.48 vs $20.52 close before publication (Sep 28) · not market-adjusted
BBNX chart →
